000			02156nam a22002297a 4500
999			_c2074 _d2074
003			OSt
005			20190101141753.0
008			190101b ||||| |||| 00| 0 eng d
020			_a978-93-5177-839-4
028			_bAllied Informatics, Jaipur _c5712 _d17/12/2018 _q2018-19
040			_aBSDU _bEnglish _cBSDU
082			_a338.092 _bSIN
100			_aSingh, Seema
245			_aMythbreaker: Kiran Mazumdar-shaw and the story of Indian Biotech
260			_aNoida _bHarper Collins Publishers _c2016
300			_a324
504			_aContents: Brewing a Business A Decade with Unilever Birth of a Cluster Transformation: From Enzymes to Drugs Diversification: Closing the Life Sciences Loop Start-up Becomes a Corporate Big, Hairy Bets The Start-up Industry Public Life The Road Ahead
520			_aAt the age of twenty-five, Kiran Mazumdar-Shaw partnered with an Irish entrepreneur, Leslie Auchincloss, to start Biocon India in a garage in Bengaluru. Armed with just a degree in beer making, this move to industrial enzymes and commodity small molecules was as audacious as it was far-sighted. Thirty-seven years on, Biocon is India’s largest research-driven biotech enterprise. And the accidental entrepreneur, Mazumdar-Shaw, is today a tough negotiator and a habitual dealmaker, casually breaking several myths about Indian women in business. Without a supportive academic ecosystem for biotechnology and in the absence of sound policymaking, Mazumdar-Shaw has tirelessly sought out global alliances and resources in her quest for ideas and molecules. To some extent, she has also plugged the brain drain of Indian scientists, making them collaborators in the fight against diabetes and cancer, and creating a space for research in India. In Mythbreaker, author Seema Singh brings alive Mazumdar-Shaw’s three-decade journey through a motley cast of characters – scientists, ministries, pharma rivals, FMCG giants – who came together to produce a narrative that is remarkable for its randomness, luck and relentless pursuit of the next scientific breakthrough.
650			_aManagement
650			_aEntrepreneurship
942			_2ddc _cBK